Reuptake¶
Transporter-mediated removal of a released neurotransmitter from extracellular synaptic space into a neuron or glial cell.
Core Idea¶
Reuptake is inward transporter-mediated movement of an already released neurotransmitter from synaptic or perisynaptic extracellular space into a neuron or glial cell. Its necessary roles are the extracellular transmitter, a membrane transporter on the receiving cell, and flux into that cell. The subsequent fate of the molecule may be repackaging, conversion, or another process; it is not part of reuptake's definition.[synapse][ref-113774420548]
Scope of Application¶
Serotonin may return to a presynaptic terminal through its transporter, whereas glutamate may enter an astrocyte and then be converted to glutamine. These differ in receiving cell and subsequent chemistry but share the extracellular-to-cellular clearance relation. Acute escitalopram changed serotonin dynamics in a specified mouse hippocampal experiment; the finding is not a general clinical effect claim.[synapse][pharm][ref-a4724a9f9ac6][ref-113774420548]
Clarity¶
“Back” does not require return to the cell that released the molecule. Receptor binding, diffusion away, extracellular enzymatic breakdown, and intracellular vesicular loading are neighboring events, not this transport step. A reuptake inhibitor acts on the pathway but is not the pathway.[synapse][pharm]
Manages Complexity¶
The three-role test separates clearance from the broader neurotransmitter lifecycle: Was the molecule already released outside cells? Did a membrane transporter move it into a neuron or glial cell? Which direction was the movement? Only then should one ask about ion coupling, recycling, metabolism, and pharmacological effects.[synapse][ref-113774420548]
Abstract Reasoning¶
An extracellular concentration reflects release, transporter uptake and other losses together. A concentration rise therefore does not by itself prove reduced reuptake. In a controlled intervention, weakening transporter activity can reduce that inward clearance term; the observed response still depends on the circuit and concurrent release and loss processes.[synapse][ref-a4724a9f9ac6]
Knowledge Transfer¶
The same structural relation appears in presynaptic serotonin uptake and astroglial glutamate uptake. The substrate after release, transporter-bearing receiving cell, and inward flux transfer; direct vesicle reuse does not. Outside neurotransmitter signaling, analogous clearance should not be labeled this reuptake identity without the same released-transmitter pathway.[synapse][ref-113774420548]
[^synapse]: OpenStax, Anatomy and Physiology, §12.5, directly checked synapse and neurotransmitter-system discussion. [^pharm]: OpenStax, Introduction to Behavioral Neuroscience, §14.1, directly checked transmitter lifecycle and SSRI example. [^ref-a4724a9f9ac6]: Saylor et al., “In vivo Hippocampal Serotonin Dynamics in Male and Female Mice: Determining Effects of Acute Escitalopram Using Fast Scan Cyclic Voltammetry”, Frontiers in Neuroscience 13:362 (2019), mouse experiment. [^ref-113774420548]: Schousboe, Bak and Waagepetersen, “Astrocytic Control of Biosynthesis and Turnover of the Neurotransmitters Glutamate and GABA”, Frontiers in Endocrinology (2013), glutamate/glutamine discussion.
Neighborhood in Abstraction Space¶
Reuptake sits in a sparse region of the domain-specific corpus (78th percentile for distinctiveness): few abstractions share its structure, so a faithful description tends to retrieve it precisely.
Family — Drug Action & Receptor Pharmacology (16 abstractions)
Nearest neighbors
- Reuptake inhibitor — 0.89
- Neurotransmission — 0.85
- Retrograde Signaling — 0.83
- Axonal Transport — 0.82
- First-Pass Metabolism — 0.81
Computed from structural-signature embeddings · 2026-10-08